ID   GRB2_RAT                Reviewed;         217 AA.
AC   P62994; P29354; Q14450; Q5BKA7; Q63057; Q63059;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 1.
DT   02-OCT-2024, entry version 175.
DE   RecName: Full=Growth factor receptor-bound protein 2;
DE   AltName: Full=Adapter protein GRB2;
DE   AltName: Full=Protein Ash;
DE   AltName: Full=SH2/SH3 adapter GRB2;
GN   Name=Grb2; Synonyms=Ash;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Fischer 344; TISSUE=Brain;
RX   PubMed=1384039; DOI=10.1073/pnas.89.19.9015;
RA   Matuoka K., Yamakawa A., Shibata M., Takenawa T.;
RT   "Cloning of ASH, a ubiquitous protein composed of one Src homology region
RT   (SH) 2 and two SH3 domains, from human and rat cDNA libraries.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:9015-9019(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND FUNCTION.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=7775428; DOI=10.1074/jbc.270.23.13733;
RA   Watanabe K., Fukuchi T., Hosoya H., Shirasawa T., Matsuoka K., Miki H.,
RA   Takenawa T.;
RT   "Splicing isoforms of rat Ash/Grb2. Isolation and characterization of the
RT   cDNA and genomic DNA clones and implications for the physiological roles of
RT   the isoforms.";
RL   J. Biol. Chem. 270:13733-13739(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 11-21; 77-86; 101-109; 125-136; 143-149 AND 208-215,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [5]
RP   INTERACTION WITH CSF1R.
RX   PubMed=8262059; DOI=10.1002/j.1460-2075.1993.tb06211.x;
RA   van der Geer P., Hunter T.;
RT   "Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase binding
RT   site, abrogates signal transduction by the murine CSF-1 receptor expressed
RT   in Rat-2 fibroblasts.";
RL   EMBO J. 12:5161-5172(1993).
RN   [6]
RP   INTERACTION WITH IRS1.
RX   PubMed=8388384; DOI=10.1016/s0021-9258(18)82106-8;
RA   Tobe K., Matuoka K., Tamemoto H., Ueki K., Kaburagi Y., Asai S.,
RA   Noguchi T., Matsuda M., Tanaka S., Hattori S., Fukui Y., Akanuma Y.,
RA   Yazaki Y., Takenawa T., Kadowaki T.;
RT   "Insulin stimulates association of insulin receptor substrate-1 with the
RT   protein abundant Src homology/growth factor receptor-bound protein 2.";
RL   J. Biol. Chem. 268:11167-11171(1993).
CC   -!- FUNCTION: Non-enzymatic adapter protein that plays a pivotal role in
CC       precisely regulated signaling cascades from cell surface receptors to
CC       cellular responses, including signaling transduction and gene
CC       expression (PubMed:7775428). Thus, participates in many biological
CC       processes including regulation of innate and adaptive immunity,
CC       autophagy, DNA repair or necroptosis. Controls signaling complexes at
CC       the T-cell antigen receptor to facilitate the activation,
CC       differentiation, and function of T-cells. Mechanistically, engagement
CC       of the TCR leads to phosphorylation of the adapter protein LAT, which
CC       serves as docking site for GRB2. In turn, GRB2 establishes a a
CC       connection with SOS1 that acts as a guanine nucleotide exchange factor
CC       and serves as a critical regulator of KRAS/RAF1 leading to MAPKs
CC       translocation to the nucleus and activation. Functions also a role in
CC       B-cell activation by amplifying Ca(2+) mobilization and activation of
CC       the ERK MAP kinase pathway upon recruitment to the phosphorylated B-
CC       cell antigen receptor (BCR). Plays a role in switching between
CC       autophagy and programmed necrosis upstream of EGFR by interacting with
CC       components of necrosomes including RIPK1 and with autophagy regulators
CC       SQSTM1 and BECN1. Regulates miRNA biogenesis by forming a functional
CC       ternary complex with AGO2 and DICER1. Functions in the replication
CC       stress response by protecting DNA at stalled replication forks from
CC       MRE11-mediated degradation. Mechanistically, inhibits RAD51 ATPase
CC       activity to stabilize RAD51 on stalled replication forks. Additionally,
CC       directly recruits and later releases MRE11 at DNA damage sites during
CC       the homology-directed repair (HDR) process.
CC       {ECO:0000250|UniProtKB:P62993, ECO:0000269|PubMed:7775428}.
CC   -!- SUBUNIT: Homodimer. Associates (via SH2 domain) with activated EGF and
CC       PDGF receptors (tyrosine phosphorylated) (By similarity). Interacts
CC       with PDGFRA (tyrosine phosphorylated); the interaction may be indirect
CC       (By similarity). Also associates to other cellular Tyr-phosphorylated
CC       proteins such as SIT1, IRS1, IRS4, SHC and LNK; probably via the
CC       concerted action of both its SH2 and SH3 domains. It also seems to
CC       interact with RAS in the signaling pathway leading to DNA synthesis.
CC       Interacts with SOS1. Forms a complex with MUC1 and SOS1, through
CC       interaction of the SH3 domains with SOS1 and the SH2 domain with
CC       phosphorylated MUC1. Interacts with phosphorylated MET (By similarity).
CC       Interacts with phosphorylated TOM1L1 (By similarity). Interacts with
CC       the phosphorylated C-terminus of SH2B2. Interacts with phosphorylated
CC       SIT1, LAX1, LAT, LAT2 and LIME1 upon TCR and/or BCR activation.
CC       Interacts with NISCH, PTPNS1 and REPS2 (By similarity). Interacts with
CC       syntrophin SNTA1 (By similarity). Interacts (via SH3 domains) with
CC       REPS1 (By similarity). Interacts (via SH3 domains) with PIK3C2B.
CC       Interacts with CBL and CBLB (By similarity). Interacts with AJUBA and
CC       CLNK (By similarity). Interacts (via SH2 domain) with TEK/TIE2
CC       (tyrosine phosphorylated) (By similarity). Interacts with SHB,
CC       INPP5D/SHIP1, SKAP1 and SKAP2 (By similarity). Interacts with PTPN11
CC       (By similarity). Interacts with PRNP (By similarity). Interacts with
CC       RALGPS1. Interacts with HCST (By similarity). Interacts with KDR (By
CC       similarity). Interacts with FLT1 (tyrosine-phosphorylated) (By
CC       similarity). Interacts with GAPT and PTPRE. Interacts (via SH2 domain)
CC       with KIF26A. Interacts (via SH3 2) with GAB2. Interacts with ADAM15 (By
CC       similarity). Interacts with THEMIS2 (By similarity). Interacts (via SH2
CC       domain) with AXL (phosphorylated). Interacts (via SH2 domain) with KIT
CC       (phosphorylated). Interacts with PTPRJ and BCR. Interacts with PTPN23.
CC       Interacts with FLT4 (tyrosine phosphorylated). Interacts with EPHB1 and
CC       SHC1; activates the MAPK/ERK cascade to regulate cell migration. Part
CC       of a complex including TNK2, GRB2, LTK and one receptor tyrosine kinase
CC       (RTK) such as AXL and PDGFRL, in which GRB2 promotes RTK recruitment by
CC       TNK2. Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated).
CC       Interacts with ERBB4. Interacts with NTRK1 (phosphorylated upon ligand-
CC       binding). Interacts with PTK2/FAK1 (tyrosine phosphorylated). Interacts
CC       with PTK2B/PYK2 (tyrosine phosphorylated). Interacts (via SH3 domains)
CC       with GAREM1 isoform 1 (via proline-rich domain and tyrosine
CC       phosphorylated); the interaction occurs upon EGF stimulation (By
CC       similarity). Interacts with DAB2 (By similarity). Interacts with TESPA1
CC       (By similarity). Interacts with PLCG1, LAT and THEMIS upon TCR
CC       activation in thymocytes; the association is weaker in the absence of
CC       TESPA1 (By similarity). Interacts with CD28 (By similarity). Interacts
CC       with RAB13; may recruit RAB13 to the leading edge of migrating
CC       endothelial cells where it can activate RHOA (By similarity). Interacts
CC       with ASAP3 (phosphorylated form) (By similarity). Interacts (via SH2
CC       domain) with PTPRH (phosphorylated form) (By similarity). Interacts
CC       with PTPRO (phosphorylated form) (By similarity). Interacts with PTPRB
CC       (phosphorylated form) (By similarity). Interacts (via SH3 domain 2)
CC       with PRR14 (via proline-rich region). Interacts with FCRL6 (tyrosine
CC       phosphorylated form). Interacts with RHEX (via tyrosine-phosphorylated
CC       form). Interacts with DENND2B. Interacts with SPRY2 (By similarity).
CC       Interacts with LRRC8A (By similarity). Interacts with PEAK1 (By
CC       similarity). Interacts with CD28 (By similarity). Interacts with FCRL1
CC       (By similarity). Interacts with RAD51; the interaction inhibits RAD51
CC       ATPase to stabilize RAD51-DNA complex at stalled replication forks.
CC       Interacts with MRE11; this interaction recruits MRE11 to the DNA damage
CC       sites. Interacts with RIPK1 ans SQSTM1; these interactions play a
CC       critical role in regulating programmed necrosis (By similarity).
CC       Interacts with AGO2; this interaction is important for the formation of
CC       a ternary complex containing GRB2, AGO2 and DICER1 (By similarity).
CC       {ECO:0000250|UniProtKB:P62993, ECO:0000250|UniProtKB:Q60631}.
CC   -!- INTERACTION:
CC       P62994; P21575: Dnm1; NbExp=3; IntAct=EBI-401775, EBI-80070;
CC       P62994; P35739: Ntrk1; NbExp=6; IntAct=EBI-401775, EBI-976667;
CC       P62994; P18545: PDE6G; Xeno; NbExp=2; IntAct=EBI-401775, EBI-2622029;
CC       P62994; P18031: PTPN1; Xeno; NbExp=3; IntAct=EBI-401775, EBI-968788;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P62993}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P62993}. Endosome
CC       {ECO:0000250|UniProtKB:P62993}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:Q60631}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Ash-L;
CC         IsoId=P62994-1, P29354-1;
CC         Sequence=Displayed;
CC       Name=2; Synonyms=Ash-M;
CC         IsoId=P62994-2, P29354-3;
CC         Sequence=VSP_001840;
CC       Name=3; Synonyms=Ash-S;
CC         IsoId=P62994-3, P29354-4;
CC         Sequence=VSP_001838;
CC   -!- TISSUE SPECIFICITY: Wide tissue distribution.
CC       {ECO:0000269|PubMed:1384039}.
CC   -!- DOMAIN: The SH3 domains mediate interaction with RALGPS1 and SHB.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation of Tyr-209 in the C-terminal SH3 domain reduces
CC       its binding to SOS1. {ECO:0000250|UniProtKB:P62993}.
CC   -!- PTM: Ubiquitinated by RNF173, leading to proteasomal degradation and
CC       inhibition of the RAF/MEK/ERK pathway. In the nucleus,
CC       polyubiquitinated by RBBP6 at Lys-109 at DNA damage sites.
CC       {ECO:0000250|UniProtKB:P62993}.
CC   -!- SIMILARITY: Belongs to the GRB2/sem-5/DRK family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X62853; CAA44665.1; -; mRNA.
DR   EMBL; D49846; BAA08645.1; -; mRNA.
DR   EMBL; D49847; BAA08646.1; -; mRNA.
DR   EMBL; BC091144; AAH91144.1; -; mRNA.
DR   PIR; S26050; S26050.
DR   RefSeq; NP_110473.2; NM_030846.2. [P62994-1]
DR   AlphaFoldDB; P62994; -.
DR   BMRB; P62994; -.
DR   SMR; P62994; -.
DR   BioGRID; 249501; 13.
DR   CORUM; P62994; -.
DR   IntAct; P62994; 27.
DR   MINT; P62994; -.
DR   STRING; 10116.ENSRNOP00000005347; -.
DR   iPTMnet; P62994; -.
DR   PhosphoSitePlus; P62994; -.
DR   SwissPalm; P62994; -.
DR   jPOST; P62994; -.
DR   PaxDb; 10116-ENSRNOP00000005347; -.
DR   Ensembl; ENSRNOT00000095127.1; ENSRNOP00000080275.1; ENSRNOG00000003990.7. [P62994-2]
DR   Ensembl; ENSRNOT00055057024; ENSRNOP00055047104; ENSRNOG00055032965. [P62994-1]
DR   Ensembl; ENSRNOT00060033412; ENSRNOP00060027341; ENSRNOG00060019266. [P62994-1]
DR   Ensembl; ENSRNOT00065034927; ENSRNOP00065028065; ENSRNOG00065020618. [P62994-1]
DR   GeneID; 81504; -.
DR   KEGG; rno:81504; -.
DR   AGR; RGD:619758; -.
DR   CTD; 2885; -.
DR   RGD; 619758; Grb2.
DR   VEuPathDB; HostDB:ENSRNOG00000003990; -.
DR   eggNOG; KOG3601; Eukaryota.
DR   GeneTree; ENSGT00940000155738; -.
DR   HOGENOM; CLU_073617_1_0_1; -.
DR   InParanoid; P62994; -.
DR   OrthoDB; 25371at2759; -.
DR   PhylomeDB; P62994; -.
DR   TreeFam; TF354288; -.
DR   Reactome; R-RNO-109704; PI3K Cascade.
DR   Reactome; R-RNO-112412; SOS-mediated signalling.
DR   Reactome; R-RNO-1250347; SHC1 events in ERBB4 signaling.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-RNO-1433557; Signaling by SCF-KIT.
DR   Reactome; R-RNO-1433559; Regulation of KIT signaling.
DR   Reactome; R-RNO-167044; Signalling to RAS.
DR   Reactome; R-RNO-179812; GRB2 events in EGFR signaling.
DR   Reactome; R-RNO-180292; GAB1 signalosome.
DR   Reactome; R-RNO-180336; SHC1 events in EGFR signaling.
DR   Reactome; R-RNO-182971; EGFR downregulation.
DR   Reactome; R-RNO-186763; Downstream signal transduction.
DR   Reactome; R-RNO-1963640; GRB2 events in ERBB2 signaling.
DR   Reactome; R-RNO-1963642; PI3K events in ERBB2 signaling.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-RNO-210993; Tie2 Signaling.
DR   Reactome; R-RNO-2179392; EGFR Transactivation by Gastrin.
DR   Reactome; R-RNO-2424491; DAP12 signaling.
DR   Reactome; R-RNO-2428933; SHC-related events triggered by IGF1R.
DR   Reactome; R-RNO-2730905; Role of LAT2/NTAL/LAB on calcium mobilization.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-RNO-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-RNO-375165; NCAM signaling for neurite out-growth.
DR   Reactome; R-RNO-388841; Costimulation by the CD28 family.
DR   Reactome; R-RNO-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-RNO-391160; Signal regulatory protein family interactions.
DR   Reactome; R-RNO-5654688; SHC-mediated cascade:FGFR1.
DR   Reactome; R-RNO-5654689; PI-3K cascade:FGFR1.
DR   Reactome; R-RNO-5654693; FRS-mediated FGFR1 signaling.
DR   Reactome; R-RNO-5654695; PI-3K cascade:FGFR2.
DR   Reactome; R-RNO-5654699; SHC-mediated cascade:FGFR2.
DR   Reactome; R-RNO-5654700; FRS-mediated FGFR2 signaling.
DR   Reactome; R-RNO-5654704; SHC-mediated cascade:FGFR3.
DR   Reactome; R-RNO-5654706; FRS-mediated FGFR3 signaling.
DR   Reactome; R-RNO-5654710; PI-3K cascade:FGFR3.
DR   Reactome; R-RNO-5654712; FRS-mediated FGFR4 signaling.
DR   Reactome; R-RNO-5654719; SHC-mediated cascade:FGFR4.
DR   Reactome; R-RNO-5654720; PI-3K cascade:FGFR4.
DR   Reactome; R-RNO-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-RNO-5654727; Negative regulation of FGFR2 signaling.
DR   Reactome; R-RNO-5654732; Negative regulation of FGFR3 signaling.
DR   Reactome; R-RNO-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-RNO-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6807004; Negative regulation of MET activity.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-74749; Signal attenuation.
DR   Reactome; R-RNO-74751; Insulin receptor signalling cascade.
DR   Reactome; R-RNO-8851805; MET activates RAS signaling.
DR   Reactome; R-RNO-8851907; MET activates PI3K/AKT signaling.
DR   Reactome; R-RNO-8853659; RET signaling.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8865999; MET activates PTPN11.
DR   Reactome; R-RNO-8875555; MET activates RAP1 and RAC1.
DR   Reactome; R-RNO-8875656; MET receptor recycling.
DR   Reactome; R-RNO-8983432; Interleukin-15 signaling.
DR   Reactome; R-RNO-9013420; RHOU GTPase cycle.
DR   Reactome; R-RNO-9027284; Erythropoietin activates RAS.
DR   Reactome; R-RNO-9028731; Activated NTRK2 signals through FRS2 and FRS3.
DR   Reactome; R-RNO-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-RNO-912631; Regulation of signaling by CBL.
DR   Reactome; R-RNO-9607240; FLT3 Signaling.
DR   Reactome; R-RNO-9674555; Signaling by CSF3 (G-CSF).
DR   Reactome; R-RNO-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   Reactome; R-RNO-9842663; Signaling by LTK.
DR   PRO; PR:P62994; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003990; Expressed in spleen and 20 other cell types or tissues.
DR   GO; GO:0005938; C:cell cortex; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0008180; C:COP9 signalosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0070436; C:Grb2-EGFR complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0012506; C:vesicle membrane; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0046875; F:ephrin receptor binding; ISO:RGD.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IPI:RGD.
DR   GO; GO:0005091; F:guanyl-nucleotide exchange factor adaptor activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0043560; F:insulin receptor substrate binding; IPI:RGD.
DR   GO; GO:0005168; F:neurotrophin TRKA receptor binding; ISO:RGD.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:RGD.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; IPI:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISO:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; ISS:UniProtKB.
DR   GO; GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; ISO:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; ISO:RGD.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0060670; P:branching involved in labyrinthine layer morphogenesis; ISO:RGD.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; ISO:RGD.
DR   GO; GO:0035987; P:endodermal cell differentiation; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0042552; P:myelination; ISO:RGD.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; ISO:RGD.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:RGD.
DR   GO; GO:0031623; P:receptor internalization; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0014044; P:Schwann cell development; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0042770; P:signal transduction in response to DNA damage; ISO:RGD.
DR   CDD; cd09941; SH2_Grb2_like; 1.
DR   CDD; cd11949; SH3_GRB2_C; 1.
DR   CDD; cd11946; SH3_GRB2_N; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 2.
DR   InterPro; IPR043539; Grb2-like.
DR   InterPro; IPR035643; GRB2_C_SH3.
DR   InterPro; IPR035641; GRB2_N_SH3.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR46037:SF4; GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; 1.
DR   PANTHER; PTHR46037; PROTEIN ENHANCER OF SEVENLESS 2B; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   PRINTS; PR00499; P67PHOX.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 2.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   SUPFAM; SSF50044; SH3-domain; 2.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Endosome; Golgi apparatus; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; SH2 domain; SH3 domain; Ubl conjugation.
FT   CHAIN           1..217
FT                   /note="Growth factor receptor-bound protein 2"
FT                   /id="PRO_0000088201"
FT   DOMAIN          1..58
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          60..152
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          156..215
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P62993"
FT   MOD_RES         6
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62993"
FT   MOD_RES         50
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62993"
FT   MOD_RES         109
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62993"
FT   MOD_RES         209
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P62993"
FT   MOD_RES         211
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P62993"
FT   CROSSLNK        109
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P62993"
FT   VAR_SEQ         60..217
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7775428"
FT                   /id="VSP_001838"
FT   VAR_SEQ         157..170
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7775428"
FT                   /id="VSP_001840"
SQ   SEQUENCE   217 AA;  25206 MW;  83A4B0BA1B248DC4 CRC64;
     MEAIAKYDFK ATADDELSFK RGDILKVLNE ECDQNWYKAE LNGKDGFIPK NYIEMKPHPW
     FFGKIPRAKA EEMLSKQRHD GAFLIRESES APGDFSLSVK FGNDVQHFKV LRDGAGKYFL
     WVVKFNSLNE LVDYHRSTSV SRNQQIFLRD IEQVPQQPTY VQALFDFDPQ EDGELGFRRG
     DFIHVMDNSD PNWWKGACHG QTGMFPRNYV TPVNRNV
//
